Lazard Asset Management LLC Standard Biotools Inc. Transaction History

Lazard Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2016 Aug 07, 2019	SELL	N/A	-35,900 Reduced 11.28%	282,275 $2.26 Million
Q2 2016 Jul 29, 2019	SELL	N/A	-71,800 Reduced 18.41%	318,175 $2.87 Million
Q1 2016 Jul 25, 2019	SELL	N/A	-251 Reduced 0.06%	389,975 $3.15 Million
Q4 2015 Jul 24, 2019	SELL	N/A	-149,904 Reduced 27.75%	390,226 $4.22 Million
Q3 2015 Jul 15, 2019	BUY	N/A	112,246 Added 26.23%	540,130 $4.38 Million
Q2 2015 Jul 08, 2019	BUY	N/A	168,884 Added 65.21%	427,884 $10.4 Million
Q4 2014 Aug 29, 2019	BUY	N/A	259,000	259,000 $8.74 Million

143

279M

27.2K

34.1K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $131M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Lazard Asset Management LLC with notifications on news.